Overview
Htl-Strefa is a global leader in the production of medical devices, specifically safe lancets, personal lancets, injection needles, and reusable lancing devices. Their products are used by medical personnel for capillary blood sampling in diagnostic tests in hospitals, clinics, and laboratories, as well as by diabetics for daily blood sugar monitoring and subcutaneous medication delivery, including insulin. The company has been operating for 25 years.
Financials
Revenue history (in m)
Data and insights are generated automatically based on financial statements and may contain errors. This analysis is for informational purposes only and does not constitute an official assessment of the company's credibility or business advice.
Statistics
How the company ranks by revenue within its industry, region and across Poland in 2025.
Results vs industry
Industry
Bank accounts
Registered as a VAT taxpayer on 2000-07-03. Active
51 1050 0086 1000 0090 8388 6714- 09 1050 0086 1000 0090 8070 7228
- 62 1050 0086 1000 0090 3138 0901
Debt
No entries in the National Debtors Register (KRZ). No proceedings in KRZ
MSiG notices
27 notices recorded in the Court and Commercial Gazette (MSiG).
| Publication date | Event | |
|---|---|---|
| Dec 14, 2021 | Call to creditors | |
| Oct 8, 2018 | Commercial Companies Code notice | |
| Sep 4, 2017 | Commercial Companies Code notice | |
| Apr 27, 2017 | Commercial Companies Code notice | |
| Mar 8, 2017 | Commercial Companies Code notice |
Public aid
12 public aid cases recorded, with a total value of $15,157,711.
| Grant date | Purpose | Gross amount | Granting body | |
|---|---|---|---|---|
| Mar 31, 2026 | Regional investment aid | –– | PIERWSZY MAZOWIECKI URZĄD SKARBOWY W WARSZAWIE | |
| Mar 31, 2025 | Regional investment aid | –– | PIERWSZY MAZOWIECKI URZĄD SKARBOWY W WARSZAWIE | |
| Apr 2, 2024 | Regional investment aid | –– | PIERWSZY MAZOWIECKI URZĄD SKARBOWY W WARSZAWIE |
European Funds
| Start | Project | EU co-financing | Programme | |
|---|---|---|---|---|
| 2016-10-01 | Opracowanie zweryfikowanych i zwalidowanych prototypów bezpiecznych igieł pasywnych do iniekcji podskórnych i dożylnych eliminujących ryzyko przypadkowego zakłucia wraz z technologią ich produkcji. | $1.7M$1,676,183 | Program Operacyjny Inteligentny Rozwój |
Tenders
No recorded participation in tenders.
Trademarks
HTL-Strefa holds 8 active trademarks registered with the Polish Patent Office. 1 mark has expired or was not registered. The first mark was filed in 1998.
| Mark | Protected until | |
|---|---|---|
| WE CARE | Oct 31, 2027 | |
| HAEMOFINE(word) | Jul 1, 2029 | |
| MediSafe SOLO | Feb 13, 2029 | |
| Acti-Lance | Feb 13, 2029 | |
| HTL STREFA(word) | Dec 24, 2034 |
Regulatory authorisations
| Authority | Type | Status | |
|---|---|---|---|
 BDO | Waste generation | Active |
Authorized Representatives
Manner of representation
Each member of the management board is authorised to represent the company and make declarations on its behalf independently.
Supervisory board
Beneficial owners
| Person | Rights |
|---|---|
Competitors
| Name | Revenue | Website | ||
|---|---|---|---|---|
| Metrum Cryoflexsp. z o.o. | $10,949,020.49 | metrum.com.pl | ||
| Poldentsp. z o.o. | $9,440,759.21 | poldent.pl | ||
| Corning HtlS.A. | $8,708,960.49 | htl.pl |
Change history
| Date | Event | |
|---|---|---|
| 2015-07-03 | Share capital change (229,569,449.65 PLN → 2,934,421.10 PLN) | |
| 2015-05-28 | Share capital change (228,117,500.00 PLN → 229,569,449.65 PLN) | |
| 2015-03-19 | Name change ("htl-Strefa" → Htl-Strefa) | |
| 2015-03-19 | PKD change (Removed: 47.99.Z, 49.41.Z, 52.10.B, 64.20.Z, 70.22.Z, 71.20.B, 72.19.Z, 73.11.Z, 73.20.Z) | |
| 2011-12-16 | Share capital change (647,500.00 PLN → 228,117,500.00 PLN) |
FAQ
Last updated: 2026-10-06